ArticleJournal of translational internal medicine2025

A signature of plasma exosomal miRNAs predict therapeutic efficacy to neoadjuvant immunotherapy in patients with non-small cell lung cancer.

Wenyu Zhai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.